News & Analysis on Clinical Trial Services & Contract Research And Development
The increasingly crowded Chinese preclinical model market gained a new entrant last month with US preclinical CRO Crown Bioscience partnering with Shanghai academics to set up a research centre.
GSK has committed itself to the UK for the long-term with an investment of £200m ($328m) across two of its manufacturing sites.
Italian CRO Centro Ricerche Cliniche di Verona (CRC) has become the first firm to be awarded a new early phase accreditation from the European CROs Federation (EUCROF).
update
Early-stage development services firm Quotient Clinical has been bought by private equity organization, Bridgepoint Development Capital.